SEC Filing Summary for Elanco Animal Health Inc.

Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., acquired 8,320.1 Deferred Stock Units on April 17, 2026. Each unit represents the right to one share of the Company's common stock or its cash equivalent. These units settle in cash or shares following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan. The acquisition was made under transaction code "A," indicating an automatic acquisition. Post-transaction, Mr. VanHimbergen owns 65,746.7 shares. The transaction was reported on Form 4, filed on April 21, 2026.